21 CFR Part 212 - CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS
- Subpart A—General Provisions (§§ 212.1 - 212.5)
- Subpart B—Personnel and Resources (§ 212.10)
- Subpart C—Quality Assurance (§ 212.20)
- Subpart D—Facilities and Equipment (§ 212.30)
- Subpart E—Control of Components, Containers, and Closures (§ 212.40)
- Subpart F—Production and Process Controls (§ 212.50)
- Subpart G—Laboratory Controls (§§ 212.60 - 212.61)
- Subpart H—Finished Drug Product Controls and Acceptance (§§ 212.70 - 212.71)
- Subpart I—Packaging and Labeling (§ 212.80)
- Subpart J—Distribution (§ 212.90)
- Subpart K—Complaint Handling (§ 212.100)
- Subpart L—Records (§ 212.110)
Authority:
Source:
74 FR 65431, Dec. 10, 2009, unless otherwise noted.